The HCPLive Psychiatry condition center page is a comprehensive resource for clinical news and insights on mental illnesses. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for depression, schizophrenia, bipolar disorder, anxiety, and more.
October 3rd 2024
A study reveals that individuals with schizophrenia spectrum disorders experience high rates of comorbid mental health conditions and receive minimally adequate treatment.
September 26th 2024
September 20th 2024
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Cancer-related Pain Experience Differs by Race, Ethnicity
With the co-occurrence of chronic pain and cancer amassing from improved cancer survival rates, it is increasingly important for healthcare professionals to understand how the conditions interrelate and influence patients' quality of life.
Vitamin D Supplementation May Reduce Pain, Improve Sleep in Knee Osteoarthritis Patients
Expanding upon previous investigations of the associations among low vitamin D levels, chronic pain, and poor sleep within the general and non-pain populations, a research poster presented at the American Pain Society 33rd Annual Scientific Meeting suggests correcting inadequate vitamin D levels in middle-aged to older patients with knee osteoarthritis may reduce their clinical pain and improve sleep quality.
Medical Marijuana Shown to Be Effective in Treating Some Symptoms of Multiple Sclerosis
April 29th 2014Literature review by the AAN shows that oral and oral spray forms of medical marijuana effectively treat some symptoms of MS, but there is little evidence to support efficacy in treating other neurologic diseases such as Parkinson's disease, epilepsy, and Tourette syndrome.
IOM Calls for Behavioral, Sociodemographic Data Collection in EHR
April 15th 2014The Institute of Medicine recently released a list of core social and behavioral health factors it suggests should be captured in all electronic health records to help healthcare providers more effectively influence patient outcomes.
Best-practice Models for Alzheimer's Disease Require Primary Care Redesign
April 4th 2014Adopting new best-practice approaches to dementia care would decrease caregiver burden, rule out onerous treatments, and improve the quality of care for older adults with Alzheimer's disease, but the current primary care structure is an obstacle to implementation.
Interneuron Levels Provide Clues into Schizophrenia and Bipolar Disorder
April 3rd 2014Schizophrenia and bipolar disorder patients have similar interneuron levels, which may provide further clues into the pathology of the mental illnesses, according to research published in the April issue of Schizophrenia Research.
Excess of Peptides Linked to Alzheimer's Disease
April 1st 2014While previous research has tied Golgi fragmentation to Alzheimer's disease (AD), an excess of Abeta peptides are behind the mechanism, according to a study published on the Proceedings of the National Academy of Sciences' website. The study also provided methods to rescue damaged cells.